558 results
Page 3 of 28
8-K
EX-2.1
t9f5b7ofh1z37
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
8jklbwglz85e
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.4
wclchk695hd2rpcquya
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
71my47
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.1
kc5a8i3l5gdrihhf4cq
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
wk8s22cfyv7ejnc0
23 Mar 22
Business combination disclosure
5:29pm
425
1tnfmih3hbul4
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
3mvrh0hk65iqn69jx95u
23 Mar 22
Business combination disclosure
5:29pm
8-K
6jpu5vo
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
pz2d z1she3j9u
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
p8wjo4hc
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.3
i891q a00p8pg5p7
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
5q7drm21
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
uh28 442xtm
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K
3c2l6db4
7 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am